⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6728155 | 0.75 | — | — | |
| SCHEMBL107405 | 0.71 | — | — | |
| SCHEMBL4332526 | 0.71 | — | — | |
| SCHEMBL8034230 | 0.69 | — | — | |
| SCHEMBL270570 | 0.68 | — | — | |
| SCHEMBL195119 | 0.68 | — | — | |
| SCHEMBL182647 | 0.67 | TDP1 (0.41) | — | |
| Bicarbonate SCHEMBL3266216 | 0.67 | FFAR3 (0.42) | — | |
| SCHEMBL11229171 | 0.65 | — | — | |
| SCHEMBL3332190 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7723470-B2 | Glycopeptide derivatives and pharmaceutical compositions containing the same | THERAVANCE, INC. (US) | 2010-05-25 | — | — | US | disclosed |
| US-20080103292-A1 | Glycopeptide derivatives and pharmaceutical compositions containing the same | CUMBERLAND PHARMACEUTICALS INC. | 2008-05-01 | — | — | US | disclosed |